Article Text
Abstract
Although neurological manifestations of systemic lupus erythematosus (SLE) are well recognised, myelopathy complicating SLE is rare. A 35-year-old woman presented with non-specific symptoms and a respiratory tract infection but had serological evidence of SLE. She subsequently deteriorated rapidly, developing a catastrophic spinal cord syndrome. Her initial MRI was normal; but after 1 month, her encephalopathy having progressed, repeat imaging showed characteristic myelitic changes. She responded only slowly to a combination of cyclophosphamide and corticosteroids. This case exemplifies the mixed presentations of SLE, including the under-recognised ‘subpial leukomyelopathy’ of central nervous system lupus. It highlights the challenges in managing lupus-related myelopathy and the benefits of a multidisciplinary approach to care.
- sle
- myelopathy
- neuroimmunology
- rheumatology
- neuropharmacology
Statistics from Altmetric.com
Footnotes
Contributors DR did literature review and provided the first drafts of the case. AN, DP and BT were involved in management of the patient as well as writing and reviewing the case.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Fady Joseph, South Wales, UK.
Read the full text or download the PDF:
Other content recommended for you
- Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus
- THE DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS
- Demyelination in rheumatic diseases
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
- Belimumab in systemic lupus erythematosus
- PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus
- Angioedema as the presenting feature of systemic lupus erythematosus
- Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET
- Retinal disease in patients with systemic lupus erythematosus
- Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms